Global Diabetic Macular Edema Treatment Market– Industry Trends - Forecast to 2025

  • Pharmaceutical
  • Upcoming Report
  • Nov 2018
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Diabetic Macular Edema Treatment Market, By Treatment Type (Anti-VEGF, Corticosteroids, Other Off-Label Drugs, Laser Photocoagulation Therapy), Drug Delivery (Intravitreal Injections, Intravitreal Implants), End-User (Hospitals, Clinics, Home Care), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)– Industry Trends & Forecast to 2025

Market Analysis: Global Diabetic Macular Edema Treatment Market

With the rising population suffering from diabetes all around the world, the rise for Diabetic Macular Edema Treatment Market has been accelerated as the prevalence of diabetes causes Macular Edema in patients. With this trend Global Diabetic Macular Edema Treatment Market is set to register a CAGR of 1.4% in the forecast period of 2018-2025, with it rising from its initial estimated value of USD 3.5 billion in 2017 to an estimated value of 3.9 billion in 2025.

Market Definition: Global Diabetic Macular Edema Treatment Market

Diabetic Macular Edema is an anomaly originating in the macula region in which accumulation of fluid causes the patient to suffer blindness. This accumulation causes the eyes to swell up and the patients suffer from distorted vision.

This accumulation is caused by leakage of plasma constituents in patients suffering from diabetes and diabetic retinopathy.

Market Drivers: 

  • Rising population suffering from diabetes, causing diabetic macular edema in the patients is causing a rise in the demand of Diabetic Macular Edema Treatment Market.
  • Driven by the new and innovative research & development for the treatment of Diabetic Macular Edema, market is expected to have an accelerated growth

Market Restraints:

  • High medical costs for the patients and the frequent visits to the physicians is causing the patients to avoid treatment
  • Lack of long-term independent trials focusing on the treatment of Diabetic Macular Edema and lack of approval of therapeutic combination drugs for the market is also causing market restraint

Segmentation: Global Diabetic Macular Edema Treatment Market

  • By Treatment Type

    • Anti-Vascular Endothelial Growth Factor Therapy

      • Ranibizumab
      • Aflibercept

    • Corticosteroids

      • Fluocinolone acetonide
      • Dexamethasone

    • Other Off-Label Drugs

      • Triamcinolone acetonide
      • Bevacizumab
      • Pegaptanib

    • Laser Photocoagulation Therapy

  • By Drug Delivery

    • Intravitreal Injections
    • Intravitreal Implants

  • By End-User

    • Hospitals
    • Clinics
    • Home Care

  • By Geography

    • North America

      • US
      • Canada
      • Mexico

    • South America

      • Brazil
      • Argentina
      • Rest of South America

    • Europe

      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
      • Russia
      • Turkey
      • Belgium
      • Netherlands
      • Switzerland
      • Rest of Europe

    • Asia-Pacific

      • Japan
      • China
      • South Korea
      • India
      • Australia
      • Singapore
      • Thailand
      • Malaysia
      • Indonesia
      • Philippines
      • Rest of Asia Pacific

    • Middle East and Africa

      • South Africa
      • Egypt
      • Saudi Arabia
      • United Arab Emirates
      • Israel
      • Rest of Middle East & Africa

Competitive Analysis: Global Diabetic Macular Edema Treatment Market

The Global Diabetic Macular Edema Treatment Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Diabetic Macular Edema Treatment market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Market Competitors: Global Diabetic Macular Edema Treatment Market

Few of the major competitors currently working on the Global Diabetic Macular Edema Treatment market are F. Hoffmann-La Roche Ltd, Novartis AG, GlaxoSmithKline plc, Alimera Sciences, ALLERGAN, Regeneron Pharmaceuticals Inc., Pfizer Inc., Kubota Pharmaceutical Holdings Co. Ltd., Oculis, Bayer AG, Bausch & Lomb Incorporated and Jaeb Center for Health Research.

Key Insights in the report: 

  • The key market players are analyzed and their effects on the market is also observed
  • Market analysis is conducted for the forecast period of 2018 to 2025, and the market segmentations are observed during that period
  • The market drivers and restraints have been clearly analyzed for the effect that they have over the market in the forecast period of 2018 to 2025

SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 5400.00
  • 4200.00
BUY NOW ADD TO CART